Class 1 aldehyde dehydrogenases (ALDH-1) function as drug resistance g
ene products by catalyzing the irreversible conversion of aldophospham
ide, an active metabolite of cyclophosphamide, to an inert compound. B
ecause the dose-limiting toxicity of cyclophosphamide is myelosuppress
ion, retrovirus-mediated transfer of ALDH-1 to bone marrow cells has b
een proposed as a protective strategy. Here we show that expression of
ALDH-1 vectors was problematic due to low levels of ALDH-1 mRNA accum
ulation, A number of vectors containing several different ALDH-1 cDNAs
were introduced into a variety of different cell lines either by tran
sfection or transduction. Detectable ALDH-1 protein and enzyme activit
y was only seen in one transfected cell clone, Cells transduced with A
LDH-1 retroviral vectors had no detectable protein expression and very
low levels of ALDH-1 mRNA, Analogous vectors containing other drug re
sistance cDNAs led to much higher levels of steady-state mRNA, The mRN
A half-life from ALDH-1 vectors was less than 2 hr suggesting that vec
tor-derived mRNAs were destabilized by ALDH-1 coding sequences. These
results suggest that methods which increase the stability of ALDH-1 mR
NAs will be important for increased drug resistance in retrovirally tr
ansduced hematopoietic cells.